Arrowgrass Capital Partners (US)’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-1,324,891
Closed -$133M 595
2014
Q4
$133M Buy
1,324,891
+1,128,352
+574% +$87.7M 2.37% 8
2014
Q3
$13M Sell
196,539
-12,765
-6% -$838K 0.32% 53
2014
Q2
$14.6M Buy
209,304
+27,986
+15% +$1.9M 0.43% 49
2014
Q1
$13.3M Buy
181,318
+136,988
+309% +$10.2M 0.52% 43
2013
Q4
$3.05M Buy
+44,330
New +$2.87M 0.14% 106

Arrowgrass Capital Partners (US)'s CBST Position: Q1 2015 in Review

Arrowgrass Capital Partners (US) sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 1,324,891 shares — an estimated $133M sold.

Arrowgrass Capital Partners (US) first reported a position in CBST in Q4 2013 and held it in 5 quarters. The position peaked at $133M in Q4 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • Arrowgrass Capital Partners (US) reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 1,324,891 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $133M.
  • Arrowgrass Capital Partners (US) first reported a position in CUBIST PHARMACEUTICALS INC in Q4 2013 and held it in 5 quarters.
  • Arrowgrass Capital Partners (US)'s CUBIST PHARMACEUTICALS INC position peaked at $133M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q1 2015, filed 15 May 2015.